期刊文献+

阿托伐他汀对TNF-α和IL-1β诱导的大鼠主动脉内皮细胞PAPP-A表达的影响 被引量:4

Effects of atorvastatin on expression of PAPP-A induced by TNF-α and IL-1β in rat aortic endothelial cells
下载PDF
导出
摘要 目的:研究阿托伐他汀对炎症因子肿瘤坏死因子α(TNF-α)和白细胞介素-1β(IL-1β)诱导大鼠主动脉内皮细胞表达妊娠相关血浆蛋白A(PAPP-A)的影响。方法:原代培养大鼠主动脉内皮细胞,选择生长良好的第3-4代细胞用于实验。实验分组:(1)空白对照组:不加干预措施原培养液继续培养;(2)阿托伐他汀浓度组:加入浓度分别为0.1、1、10μmol/L的阿托伐他汀作用24 h;(3)阿托伐他汀时间组:加入浓度为10μmol/L的阿托伐他汀分别作用6、12、24 h;(4)阿托伐他汀干预组:加入TNF-α(60μg/L)或者IL-1β(20μg/L)作用1 h后,再加入不同浓度的阿托伐他汀(0.1、1、10μmol/L)进行培养,分别于作用6、12、24 h终止实验。MTT法观察药物对细胞增殖的影响,RT-PCR技术测定细胞中PAPP-A mRNA的表达,ELISA方法检测上清液中PAPP-A蛋白水平。结果:(1)外源性加入阿托伐他汀及TNF-α或者IL-1β后,分别作用3、6、12、24、48 h,同对照组相比,细胞增殖能力无明显变化(P<0.05),说明干预药物本身对细胞没有毒性作用。(2)单独加入阿托伐他汀,细胞PAPP-A表达水平与空白对照组比较没有明显差异(P<0.05)。(3)炎症因子作用一段时间后再加入阿托伐他汀,PAPP-A mRNA和蛋白表达水平随着阿托伐他汀浓度和作用时间的增加而逐渐降低,有一定的浓度-时间依赖关系,与TNF-α组和IL-1β组比较明显下降(P<0.05)。结论:阿托伐他汀本身对细胞表达PAPP-A没有影响,但在一定程度上抑制TNF-α和IL-1β诱导的内皮细胞PAPP-A的表达,并有浓度-时间依赖关系。 AIM: To investigate the effects of atorvastatin on the expression of pregnancy-associated plasma protein A(PAPP-A)induced by TNF-α and IL-1β in endothelial cells.METHODS: The rat aortic endothelial cells were isolated from thoracic aortas and cultured by the tissue explant method.The cells in passage 3-4 were used in the experiment and were randomly divided into 4 groups: blank control group: the cells were treated without any intervention;atorvastatin concentration groups: the cells were incubated with atorvastatin at the concentrations of 0.1,1 and 10 μmol/L for 24 h;atorvastatin time groups: the cells were incubated with atorvastatin at the concentration of 10 μmol/L for 6 h,12 h and 24 h;atorvastatin+inflammatory factors groups: the cells were pre-incubated with 60 μg/L TNF-α or 20 μg/L IL-1β for 1 h,then different concentrations of atorvastatin(0.1,1.0,10 μmol/L) were added for 6 h,12 h and 24 h.MTT reduction assay was used to observe the cell proliferation.The mRNA expression of PAPP-A was detected by RT-PCR.The protein level of PAPP-A in the supernatants of cultured cells was measured by ELISA.RESULTS: Compared with blank control group,no significant change of cell proliferation was observed after the intervention of atorvastatin and TNF-α/IL-1β for 3 h,6 h,12 h,24 h and 48 h,indicating that the drugs had no toxic effects on the cells.No significant difference of PAPP-A expression between atorvastatin groups and blank control groups was found.Compared with TNF-α groups and IL-1β groups,PAPP-A expressions in atorvastatin intervention groups significantly decreased.The protein level of PAPP-A was gradually decreased with the raised concentration of atorvastatin and the prolonged time in a concentration-and time-dependent manner.CONCLUSION: Atorvastatin doesn't influence the PAPP-A expression,but inhibits the expression of PAPP-A activated by inflammatory factors in a concentration-and time-dependent manner in primary cultured rat aortic endothelial cells.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2011年第7期1335-1341,共7页 Chinese Journal of Pathophysiology
基金 山西省高校科技研究开发资助项目(No.200811070)
关键词 动脉粥样硬化 妊娠相关血浆蛋白A 阿托伐他汀 细胞因子类 Artherosclerosis Pregnancy-associated plasma protein A Atorvastatin Cytokines
  • 相关文献

参考文献12

  • 1边云飞,赵欣,肖传实.肿瘤坏死因子α和白细胞介素1β对内皮细胞妊娠相关血浆蛋白A表达的影响[J].中国动脉硬化杂志,2009,17(4):260-264. 被引量:2
  • 2朱贵月,朱兴雷,耿庆信.阿托伐他汀对冠心病患者外周血单核细胞/巨噬细胞清道夫受体的影响[J].中国病理生理杂志,2006,22(2):292-294. 被引量:2
  • 3Rosetta Melfi,Annunziata Nusca,Giuseppe Patti,Germano Sciascio.Statins and Their Role in Pre-Percutaneous Coronary Intervention[J]. Current Cardiology Reports . 2010 (4)
  • 4Nusca A,,Melfi R,Patti G,et al.Statin loading for acutecoronary syndromes. Current Opinion in Cardiology . 2010
  • 5Wang Y,Zhang MX,Meng X,et al.Atorvastatin suppressesLPS-induced rapid upregulation of Toll-like receptor 4and its signaling pathway in endothelial cells. American Journal of Physiology Heart and Circulatory Physiology . 2011
  • 6Bayes-Genis A,Conover C A,Overgaard M T,et al.Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. New England Journal of Homeopathy . 2001
  • 7Pasterkamp G,Schoneveld A H,van der Wal A C,et al.Inflammation of the atherosclerotic cap and shoulder of the plaque is a common and locally observed feature in unruptured plaques of femoral and coronary arteries. Arteriosclerosis and Thrombosis . 1999
  • 8Torzewski J,Torzewski M,Bowyer DE,et al.C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atheroclerotic leisions of human coronary rateries. Arteriosclerosis . 1998
  • 9Howard PA,Barnes BJ.Potential use of statins to prevent atrial fi-brillation after coronary artery bypass surgery. Ann Pharmacoth-er . 2008
  • 10Ortego M,Bustos C,Hemandez-Presa MA,Tunon J,Diaz C,Hernandez G,et al.Atorvastatin reduces NF-kappaB activation and chemokine expression in bascular smooth muscle cells and mononuclear cells. Atherosclerosis . 2001

二级参考文献19

  • 1Bayes-Gneis A, Conover CA, Overgaatd MT, et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes [ J ]. N EnglJ Med, 2002, 345 (14): 1057-0S9.
  • 2Beaudeux JL, Bare L, Imbert-Bismut F, et al. Serum plasma pregnancy associated protein A: a potential marker of echogenic carotid atherosclerotie plaques in asymptomatic hyperlipidemie subjects at high eardiovaseular risk [ J ]. Arterioscler Thromb Vasc Biol, 2005, 23 (1): e7-10.
  • 3Khosravi J, Diamandi A, Krishna RG, et al. Pregnancy asmeiated plasma protein-A: ultra.sensitive immunoassay and determination in coronary heart disease [J]. Clin Biochem, 2004, 35 (7) : 531-538.
  • 4Pasceri V, Winerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells [ J ]. Circulation, 2002, 102 (18) : 2 165-168.
  • 5Sullivan GW, Sarembock IJ, Linden J. The role of inflammation in vascular diseases [ J]. J Leukoc Biol, 2002, 67 (5) : 591-602.
  • 6Chen BK, Overgaard MT, Bale LK, et al. Molecular regulation of the IGF-binding protein-4 protease system in human fibroblssts: identification of a novel inducible inhibitor [J]. Endocrinology, 2004, 143 (4) : 1 199- 205.
  • 7Conover CA, Bale LK, Harrinqton SC, et al. Cytokine stimulation of pregnancy-associated plasma protein A expression in human coronary artery smooth muscle cells: inhibition by resveratrol [J]. AM J Physiol Cell Physiol, 2006, 290 ( 1 ) : C183-188.
  • 8Resch ZT, Oxvig C, Bale LK, et al. Stress-activated signaling pathways mediate the stimulation of pregnancy-associated plasma protein-A expression in cultured human fibreblasts [ J ]. Endocrinology, 2007, 147 (2) : 885- 890.
  • 9Byun D, Mohan S, Yoo M, et al. Pregnaney-asseeiated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IG- FBP-4) ptvteolytie activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro [J]. J Clin Endocrinol Metab, 2004, 86 (2): 847-854.
  • 10Delafontaine P, Song YH, Li Y. ExpressiOn, regulation, and function of IGF-I, IGF-I R, and IGF-I binding proteins in blood vessels [ J ]. Avterioscler Thromb Vasc Biol, 2004, 24 (3) : 435-444.

共引文献2

同被引文献39

  • 1魏路清,董彦,李振华.阿托伐他汀对肺纤维化大鼠肺泡灌洗液MMP-9和TIMP-1的影响[J].浙江大学学报(医学版),2011,40(1):64-70. 被引量:6
  • 2Li X, Deroide N, Mallat Z. The role of the inflammasome in cardiovascular diseases[J]. J Mol Med, 2014, 92(4):307-319.
  • 3Robbins GR, Wen H, Ting JP. Inflammasomes and metabolic disorders:old genes in modern diseases[J]. Mol Cell, 2014, 54(2):297-308.
  • 4Martinon F, Burns K, Tschopp J. The inflammasome:a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta[J]. Mol Cell, 2002, 10(2):417-426.
  • 5Mcintire CR, Yeretssian G, Saleh M. Inflammasomes in infection and inflammation[J]. Apoptosis, 2009, 14(4):522-535.
  • 6Zernecke A, Weber C. Improving the treatment of atherosclerosis by linking anti-inflammatory and lipid modulating strategies[J]. Heart, 2012, 98(21):1600-1606.
  • 7Schroder K, Tschopp J. The inflammasomes[J]. Cell, 2010, 140(6):821-832.
  • 8Chavarría-Smith J, Vance RE. The NLRP1 inflammasomes[J]. Immunol Rev, 2015, 265(1):22-34.
  • 9Bleda S, de Haro J, Varela C, et al. NLRP1 inflammasome, and not NLRP3, is the key in the shift to proin-flammatory state on endothelial cells in peripheral arterial disease[J]. Int J Cardiol, 2014, 172(2):e282-e284.
  • 10Bleda S, De Haro J, Varela C, et al. Aspirin therapy inhibits NLRP1(nucleotide-binding domain-like receptor protein 1) inflammasome gene expression in patients with peripheral artery disease[J]. J Vasc Surg, 2015, 61(4):1103-1104.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部